CalciMedica, Inc. (CALC) vs Processa Pharmaceuticals, Inc. (PCSA)

A side-by-side comparison of CalciMedica, Inc. and Processa Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
CalciMedica, Inc. logo
CALC
CalciMedica, Inc.
$5M
$1.47HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT
Processa Pharmaceuticals, Inc. logo
PCSA
Processa Pharmaceuticals, Inc.
$4M
$1.49HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT

Total return — CALC vs PCSA

growth of $100 · dividends reinvested · last 3y
CALC -94.7% (-62.5%/yr)PCSA -99.6% (-84.0%/yr)CALC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202420252026$5$0
CALC PCSA

CALC vs PCSA: by the numbers

  • •CALC is the larger company ($5M vs $4M market cap).

Metrics side by side

Valuation

MetricCALCPCSA
P/B ratio0.84N/A

Profitability

MetricCALCPCSA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-385.27%N/A
ROIC-122.56%N/A

Growth (annualized)

MetricCALCPCSA
Total return CAGR (5Y)N/A-79.32%

Go deeper

Full CALC analysisFull PCSA analysisInteractive comparison tool

Dig into the metrics

CalciMedica ROEProcessa Pharmaceuticals ROECalciMedica operating marginProcessa Pharmaceuticals operating marginCalciMedica revenue growthProcessa Pharmaceuticals revenue growthCalciMedica free cash flowProcessa Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.